US biotech Moderna strikes deal to develop mRNA drugs in China
4 big questions ahead of Moderna's public debut — biotech's biggest ever
With new vaccine technology, small biotech firm Moderna battles mighty pandemic | The Times of Israel
Moderna's commercial lead ousted as mRNA biotech taps leading execs to front all sales, marketing work | Fierce Pharma
Moderna (MRNA) Billionaire Afeyan Adds to Fortune as Sigilon Stock (SGTX) Soars - Bloomberg
Moderna's manufacturing operations reveal state of the company
AstraZeneca sold its stake in Moderna for more than $1 billion, as it looks to develop its own pipeline of drugs - MarketWatch
Why Moderna's stock value requires an almost mythical leap of faith
 "Looking for opportunities in China after registering legal entity: Moderna | World News - Business Standard")
Looking for opportunities in China after registering legal entity: Moderna | World News - Business Standard
Covid vaccine: who is behind the Moderna breakthrough? | Coronavirus | The Guardian
Readout Newsletter: Biotech news, including Moderna's Covid vaccine
A Reckoning Is Coming for Cash-Strapped Biotechs - Bloomberg
Moderna Raises Size of its Largest-Ever Biotech IPO to $600M
US biotech: Moderna's art
Moderna Therapeutics Clinical Manufacturing Facility, Norwood
Welcome to the Office of Economy and Labour (AWA) - Moderna drives vaccine production from Basel
Moderna - Wikipedia
Be Careful Handling White-Hot Moderna Stock - WSJ
Moderna Gets OK to Start Larger Trial for a Coronavirus Vaccine - The New York Times
Moderna Sues Pfizer and BioNTech Over Covid Vaccine Technology - The New York Times
After a big year, Moderna becomes the third largest biotech employer based in Mass. - The Boston Globe
Fact check: Dr. Fauci was not the first CEO and other false claims about biotech company Moderna | Reuters
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
Moderna nears its first-ever FDA authorization, for its COVID-19 vaccine - MarketWatch
Moderna says COVID-19 vaccine supply outside United States to slow down | Reuters
Biotech Companies Moderna, Lonza Group Partner to Manufacture Potential Coronavirus Vaccine
Moderna seeks U.S. authorization for COVID-19 vaccine booster | Reuters
Transcript: Moderna's CFO on What a Biotech Company Does with $13 Billion - Bloomberg
